U.S. CDC reports 1,891,690 coronavirus cases
(Reuters) – The U.S. Centers for Disease Control and Prevention (CDC) on Saturday reported 1,891,690 cases of the new coronavirus, an increase of 29,034 cases from its previous count, and…
Fujifilm says COVID-19 drug research may drag on into July
FILE PHOTO: Tablets of Avigan (generic name : Favipiravir), a drug approved as an anti-influenza drug in Japan and developed by drug maker Toyama Chemical Co, a subsidiary of Fujifilm…
AstraZeneca scores twin drug approvals alongside vaccine progress
(Reuters) – Britain’s AstraZeneca has clinched expanded regulatory backing for two medications, including one for blockbuster cancer treatment Lynparza, in a development pipeline that now includes a possible coronavirus vaccine.…
Roche gets FDA emergency use approval for COVID-19 antibody test
FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland January 30, 2020. REUTERS/Arnd Wiegmann/File Photo (Reuters) – Roche Holding AG (ROG.S) received emergency…
U.S. FDA approves first rapid coronavirus test with 45 minutes detection time
FILE PHOTO: A computer image created by Nexu Science Communication together with Trinity College in Dublin, shows a model structurally representative of a betacoronavirus which is the type of virus…
Swiss coronavirus cases surge, canton orders seniors to stay home
ZURICH (Reuters) – Switzerland on Saturday reported 6,100 coronavirus infections, 25% more than a day earlier, and 56 deaths, the Swiss health ministry said, as the canton of Ticino that…
Bayer faces fourth U.S. Roundup cancer trial in Monsanto’s hometown
(Reuters) – Bayer AG (BAYGn.DE) is set to face a fourth U.S. jury trial over allegations that its Roundup weed killer causes cancer, with four cancer patients in the hometown…
Trump administration restricts some e-cigarette flavors
(Reuters) – The Trump administration on Thursday announced a ban on some popular e-cigarette flavors, including fruit and mint, to curb rising teenage use of vaping products, allowing only menthol…
Drug developers take fresh aim at ‘guided-missile’ cancer drugs
FRANKFURT/ZURICH (Reuters) – Dozens of drugmakers are conducting human trials for a record 89 therapies that pair antibodies with toxic agents to fight cancer, evidence of renewed confidence in an…
Biogen scraps development of therapy for rare brain disease
(Reuters) – Biogen Inc said on Friday it would discontinue the development of its experimental therapy for a rare brain disease after the treatment failed a mid-stage trial, the latest…